ストックスクリーナーアプリを入手
20.01
4.49%
-0.94
前日終値:
$20.95
開ける：
$20.96
24時間の取引高:
310.26K
Relative Volume:
0.60
時価総額：
$1.19B
収益：
-
当期純損益:
$-85.21M
株価収益率:
-10.59
EPS:
-1.89
ネットキャッシュフロー:
$-68.53M
1週間 パフォーマンス:
-1.72%
1か月 パフォーマンス:
+6.78%
6か月 パフォーマンス:
+0.45%
1年 パフォーマンス:
-7.96%
1日の値動き範囲:
$19.95
$21.02
1週間の範囲:
$19.92
$21.30
52週間の値動き範囲:
$13.30
$30.03
Enliven Therapeutics Inc Stock (ELVN) Company Profile
ELVN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ELVN
Enliven Therapeutics Inc
|
20.01 | 1.24B | 0 | -85.21M | -68.53M | -1.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Enliven Therapeutics Inc Stock (ELVN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-06-16 | 開始されました | Goldman | Buy |
| 2024-12-13 | 開始されました | BTIG Research | Buy |
| 2024-09-09 | 開始されました | H.C. Wainwright | Buy |
| 2024-06-11 | 開始されました | Robert W. Baird | Outperform |
| 2024-04-09 | 開始されました | Mizuho | Buy |
| 2023-03-29 | 開始されました | Jefferies | Buy |
すべてを表示
Enliven Therapeutics Inc (ELVN) 最新ニュース
Full technical analysis of Enliven Therapeutics Inc. stockJuly 2025 Intraday Action & Free Fast Gain Swing Trade Alerts - Newser
Enliven Therapeutics Inc. stock outlook for YEARDip Buying & Risk Controlled Stock Alerts - Newser
What is the long term forecast for Enliven Therapeutics Inc. stockJuly 2025 Sentiment & Precise Swing Trade Entry Alerts - khodrobank.com
What is Enliven Therapeutics Inc.’s valuation compared to sectorJuly 2025 Rallies & Free Fast Entry Momentum Trade Alerts - khodrobank.com
How to build a custom watchlist for Enliven Therapeutics Inc.IPO Watch & Low Drawdown Investment Strategies - Newser
How to monitor Enliven Therapeutics Inc. with trend dashboards2025 Bull vs Bear & Reliable Price Breakout Signals - Newser
Risk vs reward if holding onto Enliven Therapeutics Inc.Portfolio Return Report & Low Drawdown Trading Techniques - Newser
How to integrate Enliven Therapeutics Inc. into portfolio analysis tools2025 Geopolitical Influence & AI Driven Price Predictions - Newser
Applying Elliott Wave Theory to Enliven Therapeutics Inc.Quarterly Profit Report & AI Driven Price Forecasts - Newser
Is Enliven Therapeutics Inc. forming a double bottomTrade Risk Report & Long-Term Safe Investment Ideas - khodrobank.com
Is Enliven Therapeutics Inc. stock bottoming outJuly 2025 PostEarnings & Verified Chart Pattern Signals - Newser
Sector ETF performance correlation with Enliven Therapeutics Inc.Analyst Upgrade & Free Expert Verified Stock Movement Alerts - Newser
Can machine learning forecast Enliven Therapeutics Inc. recoveryTrade Ideas & Growth Focused Entry Reports - Newser
Is Enliven Therapeutics Inc. forming a bottoming base2025 Growth vs Value & Weekly Watchlist for Hot Stocks - Newser
Will Enliven Therapeutics Inc. bounce back from current supportJuly 2025 Pullbacks & Daily Stock Momentum Reports - Newser
Visual trend scoring systems applied to Enliven Therapeutics Inc.Gap Down & Precise Buy Zone Tips - Newser
Using data models to predict Enliven Therapeutics Inc. stock movement2025 Pullback Review & Accurate Intraday Trading Signals - Newser
Can Enliven Therapeutics Inc. hit a new high this monthJuly 2025 Outlook & Fast Entry High Yield Tips - Newser
How to interpret RSI for Enliven Therapeutics Inc. stockQuarterly Profit Summary & High Conviction Buy Zone Picks - Newser
Using Bollinger Bands to evaluate Enliven Therapeutics Inc.2025 Top Decliners & Free Risk Controlled Daily Trade Plans - Newser
Using data tools to time your Enliven Therapeutics Inc. exitJuly 2025 Decliners & Consistent Growth Equity Picks - Newser
What recovery options are there for Enliven Therapeutics Inc.Weekly Profit Recap & Verified Trade Idea Suggestions - Newser
Can volume confirm reversal in Enliven Therapeutics Inc.Trend Reversal & Low Volatility Stock Recommendations - Newser
Can Enliven Therapeutics Inc. be recession proofJuly 2025 Gainers & Free Expert Approved Momentum Trade Ideas - khodrobank.com
Can Enliven Therapeutics Inc. weather a recession2025 Technical Patterns & Technical Pattern Alert System - khodrobank.com
Enliven Therapeutics Inc. stock retracement – recovery analysisJuly 2025 Levels & Real-Time Stock Entry Alerts - Newser
Should I invest in Enliven Therapeutics Inc. before earningsJuly 2025 Drop Watch & Technical Entry and Exit Alerts - khodrobank.com
Will Enliven Therapeutics Inc. stock go up in YEAREntry Point & AI Enhanced Trading Alerts - khodrobank.com
Is Enliven Therapeutics Inc. stock risky to hold nowMarket Sentiment Review & Capital Efficient Trading Techniques - khodrobank.com
Smart tools for monitoring Enliven Therapeutics Inc.’s price actionDollar Strength & High Return Trade Opportunity Guides - Newser
How volatile is Enliven Therapeutics Inc. stock2025 Price Momentum & Growth Focused Stock Pick Reports - خودرو بانک
Enliven Therapeutics Inc. Inches Above Key Support — Safe to HoldTrade Exit Report & Free Weekly Watchlist of Top Performers - beatles.ru
Visualizing Enliven Therapeutics Inc. stock with heatmapsJuly 2025 Opening Moves & Entry and Exit Point Strategies - Newser
Combining price and volume data for Enliven Therapeutics Inc.Weekly Stock Analysis & Low Risk Profit Maximizing Plans - Newser
Enliven Therapeutics Inc (ELVN) 財務データ
収益
当期純利益
現金流量
EPS
Enliven Therapeutics Inc (ELVN) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Hohl Benjamin | CHIEF FINANCIAL OFFICER |
Aug 27 '25 |
Sale |
20.63 |
3,250 |
67,039 |
23,000 |
1.75%
1.11%
大文字化:
|
ボリューム (24 時間):